Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DAISY: BIIB131 for Acute Ischemic Stroke
NCT05764122Phase 2Withdrawn
- Sponsor
- Biogen
- Start
- Mar 2024
- Primary completion
- Jul 2025
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of JX10 in ischemic stroke, sponsored by Biogen. Planned start Mar 2024; status: withdrawn.
02
Drugs
JX10
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT05764122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05764122.